Volume 10, Number 11, November 2004

Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira,* Christopher P. Neukermans,† and Gillian D. Sanders†‡
*Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; and ‡Duke University, Durham, North Carolina, USA

Figure 3. Effect of changing frequency with which vaccinated women receive a Pap test. The diamonds represent Pap testing annually, every 2 years (base case), every 3 years, and every 4 years. The x-axis represents the lifetime expected cost of the vaccination strategy; the y-axis is the quality-adjusted life expectancy in years. The incremental cost-effectiveness of increasing the frequency of Pap testing for vaccinated women is indicated numerically above the cost-effectiveness frontier. QALY, quality-adjusted life-year.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 22, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention